Newsweek

Trump Could Stop Chinese Companies Backing North Korea

Reining in Pyongyang is possible if—and only if—Washington is willing to offend Beijing.
"Self-restraint, which is a choice, is all that separates armistice and war."
2017_07_21_Cover_1280 × 720

The city of Dandong, in China’s northeastern Liaoning province, appears to be an embarrassing relic of the country’s economic past. Old, run-down state-owned factories sit on the outskirts of a town full of dreary office buildings. There is none of the flash and glitz so prevalent in China’s far more prosperous cities.

But Dandong is nevertheless one of the most important cities in China, because it sits just across the border from North Korea and is Pyongyang’s economic lifeline. Nearly 85 percent of North Korea’s global trade is with China, and much of that flows through Dandong. That includes the machinery, purchased in contravention of both U.S. and U.N. sanctions, needed to build nuclear weapons, as well as the missiles needed to deliver them. And, crucially, Dandong is also the source of the offshore financing from Chinese banks that Pyongyang needs to pay for its illicit weapons program.

That program took yet another step forward on July 4, America’s Independence Day, when Pyongyang successfully tested a missile capable of reaching Alaska. This latest in-your-face provocation from North Korean leader Kim Jong Un came after President Donald Trump had signaled that his strategy for reining in the North—relying on China to use its clout with the Pyongyang regime—had failed. “At least we know China tried,” Trump tweeted on June 20.

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related Books & Audiobooks